Greater than 95.0% as determined by analysis by SDS-PAGE.
LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 250 amino acids and having a molecular mass of 26.2kDa. The LGALS3 is purified by proprietary chromatographic techniques.
MADNFSLHDAL SGSGNPNPQG WPGAWGNQPA GAGGYPGASY PGAYPGQAPP GAYPGQAPPG AYPGAPGAYP GAPAPGVYPG PPSGPGAYPS SGQPSATGAY PATGPYGAPA GPLIVPYNLP LPGGVVPRML ITILGTVKPN ANRIALDFQR GNDVAFHFNP RFNENNRRVI VCNTKLDNNW GREERQSVFP FESGKPFKIQ VLVEPDHFKV AVNDAHLLQY NHRVKKLNEI SKLGISGDID LTSASYTMI.
Galectin-3 is characterized by a carbohydrate recognition domain (CRD) that allows it to bind to beta-galactoside residues. This binding capability is crucial for its role in various biological processes. The protein is composed of 250 amino acids and has a molecular weight of approximately 26-31 kDa .
Cell Adhesion and Migration: Galectin-3 plays a significant role in cell adhesion and migration by interacting with cell surface glycoproteins. This interaction is essential for processes such as wound healing and immune cell trafficking .
Apoptosis Regulation: Galectin-3 has anti-apoptotic properties, meaning it can prevent programmed cell death. This function is particularly important in cancer cells, where overexpression of Galectin-3 can contribute to tumor progression and metastasis .
Immune Response: Galectin-3 is involved in modulating the immune response. It can influence the activity of various immune cells, including macrophages and T-cells, thereby playing a role in inflammation and immune regulation .
Recombinant human Galectin-3 is produced using various expression systems, including Escherichia coli (E. coli) and human embryonic kidney (HEK293) cells. The recombinant protein is often used in research to study its biological functions and potential therapeutic applications .
E. coli Expression System: In this system, the human Galectin-3 gene is inserted into a plasmid vector, which is then introduced into E. coli cells. The bacteria express the protein, which is subsequently purified. This method is cost-effective and allows for high-yield production .
HEK293 Expression System: This system involves the use of human cells to produce the recombinant protein. The HEK293 cells are transfected with the Galectin-3 gene, leading to the expression of the protein in a more native form. This method is often preferred for applications requiring high biological activity and proper post-translational modifications .
Recombinant human Galectin-3 is widely used in various research areas, including:
Cancer Research: Due to its role in apoptosis and tumor progression, Galectin-3 is a target for cancer research. Studies focus on understanding its function in cancer cells and developing potential therapeutic strategies .
Immunology: Galectin-3’s involvement in immune regulation makes it a valuable tool for studying immune responses and developing immunotherapies .
Cell Biology: Researchers use recombinant Galectin-3 to study cell adhesion, migration, and other cellular processes, providing insights into fundamental biological mechanisms .